Nyxoah (NASDAQ:NYXH – Get Free Report)‘s stock had its “sell (d-)” rating reissued by stock analysts at Weiss Ratings in a note issued to investors on Saturday,Weiss Ratings reports.
Nyxoah Trading Down 1.1%
Shares of NYXH opened at $5.61 on Friday. The stock has a market capitalization of $191.08 million, a P/E ratio of -2.44 and a beta of 1.53. The company has a quick ratio of 2.38, a current ratio of 2.63 and a debt-to-equity ratio of 0.29. The firm has a fifty day simple moving average of $5.65 and a two-hundred day simple moving average of $6.62. Nyxoah has a twelve month low of $4.34 and a twelve month high of $11.87.
Nyxoah (NASDAQ:NYXH – Get Free Report) last announced its quarterly earnings results on Monday, August 18th. The company reported ($0.63) earnings per share for the quarter, missing the consensus estimate of ($0.62) by ($0.01). The firm had revenue of $1.58 million for the quarter, compared to analysts’ expectations of $1.33 million. Nyxoah had a negative net margin of 1,541.84% and a negative return on equity of 79.18%. On average, research analysts anticipate that Nyxoah will post -1.91 EPS for the current year.
Institutional Investors Weigh In On Nyxoah
About Nyxoah
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.
Featured Stories
- Five stocks we like better than Nyxoah
- 3 Tickers Leading a Meme Stock Revival
- Tractor Supply Stock Looks Like a Buy-and-Hold Winner
- How to Calculate Retirement Income: MarketBeat’s Calculator
- 3 Stocks Well Below 52-Week Highs Poised for a Q4 Rebound
- Growth Stocks: What They Are, What They Are Not
- Big Banks Are Setting the Tone as Earnings Season Kicks Off
Receive News & Ratings for Nyxoah Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nyxoah and related companies with MarketBeat.com's FREE daily email newsletter.
